Stem cell therapy is revolutionizing the approach to treating eye damage, bringing new hope to patients with conditions once deemed untreatable.Recent clinical trials at Mass Eye and Ear have demonstrated the efficacy of this innovative technique, specifically focusing on cultivated autologous limbal epithelial cells (CALEC) for restoring damaged corneal surfaces.